InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Biotechnology and patentability: navigating unchartered waters in Australia and the US


The debate over the patentability of isolated DNA has raged around the world. Tania Obranovich compares the two Myriad decisions from the highest courts in Australia and the US and explains how the Australian decision has called into question what had long been thought of as a fundamental pillar of Australian patent law

Myriad's BRCA patents, which claim both breast cancer diagnostic methods and the isolated BRCA DNA molecules, have courted significant controversy both in Australia and the US in recent years. Extensive judicial consideration in relation to the patent eligibility of isolated...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Busy week of MIP events! #GlobalPatentForum tomorrow (Palo Alto) & Thur (Chicago) #IPStrategyForum2017 Weds (London… https://t.co/nyW2gTKPTz

Apr 24 2017 09:26 ·  reply ·  retweet ·  favourite
ManagingIP profile

Emerging markets file more patents than the west https://t.co/FkQVfMMKyk via @FT (£)

Apr 24 2017 08:07 ·  reply ·  retweet ·  favourite
ManagingIP profile

Very sorry to hear this. Wubbo received an outstanding achievement award from Managing IP in 2009… https://t.co/bz7via7FGz

Apr 22 2017 01:13 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


April 2017

Patent subject matter eligibility: A new Section 101

Calls for changing Section 101 of the Patent Act in the US are increasing. A proposed amendment from IPO shows one way to do it, reports Michael Loney



Most read articles

Supplements